- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05222100
Effect of Breast Implants om Mammography Screening
June 30, 2025 updated by: Vastra Gotaland Region
The purpose of the study is to survey how many women have breast implants in the mammography screening population and the effect of implants on the number and type of examinations and on costs.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
2500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Emma Hansson, MD,PhD
- Phone Number: +46313421000
- Email: emma.em.hansson@vgregion.se
Study Locations
-
-
-
Gothenburg, Sweden, 413 45
- Recruiting
- Sahlgrenska University Hospital
-
Contact:
- Emma Hansson, PhD
- Phone Number: +46 31 342 10 00
- Email: emma.hansson.2@gu.se
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Women participating in the mammography screening program in Gothenburg, Sweden.
Description
Inclusion Criteria:
- Women participating in the mammography screening program.
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Women without breast implants
Women without breast implants participating in the mammography screening program.
|
Breast screening mammograms use X-rays to look for cancers that are too small to see or feel.
Other Names:
|
|
Women with breast implants
Women with breast implants participating in the mammography screening program.
|
Breast screening mammograms use X-rays to look for cancers that are too small to see or feel.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Costs
Time Frame: 1 year post-operatively
|
Health economic analysis of the effects of implants on mammography screening
|
1 year post-operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevalence
Time Frame: 1 year
|
Prevalence of breast implants in a mammography screening population.
|
1 year
|
|
Frequency of need for additional examinations
Time Frame: 1 year
|
Survey of if breast implants infer extra examinations (mammography, ultrasounds, biopsies, diagnostic operations) in connection with screening mammography.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 12, 2021
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
January 23, 2022
First Submitted That Met QC Criteria
January 23, 2022
First Posted (Actual)
February 3, 2022
Study Record Updates
Last Update Posted (Actual)
July 3, 2025
Last Update Submitted That Met QC Criteria
June 30, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-01534
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.